التفاصيل البيبلوغرافية
| العنوان: |
Pharmacokinetic herb-drug interactions between Aidi injection and doxorubicin in rats with diethylnitrosamine-induced hepatocellular carcinoma. |
| المؤلفون: |
Lu, Yuan, Pan, Jie, Zhu, Xiaoqing, Zhang, Shuai, Liu, Chunhua, Sun, Jia, Li, Yueting, Chen, Siying, Huang, Jing, Cao, Chuang, Wang, Yonglin, Li, Yongjun, Liu, Ting |
| المصدر: |
BMC Pharmacology & Toxicology; 9/6/2021, Vol. 22 Issue 1, p1-8, 8p |
| مصطلحات موضوعية: |
DOXORUBICIN, DRUG-herb interactions, RATS, INJECTIONS, HEPATOCELLULAR carcinoma, LIQUID chromatography-mass spectrometry |
| مستخلص: |
Background: Aidi Injection (ADI), a Chinese herbal preparation with anti-cancer activity, is used for the treatment of hepatocellular carcinoma (HCC). Several clinical studies have shown that co-administration of ADI with doxorubicin (DOX) is associated with reduced toxicity of chemotherapy, enhanced clinical efficacy and improved quality of life for patients. However, limited information is available about the herb-drug interactions between ADI and DOX. The study aimed to investigate the pharmacokinetic mechanism of herb-drug interactions between ADI and DOX in a rat model of HCC. Methods: Experimental HCC was induced in rats by oral administration of diethylnitrosamine. The HCC rats were pretreated with ADI (10 mL/kg, intraperitoneal injection) for 14 consecutive days prior to administration of DOX (7 mg/kg, intravenous injection) to investigate pharmacokinetic interactions. Plasma concentrations of DOX and its major metabolite, doxorubicinol (DOXol), were determined using ultra-performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS). Results: Preadministration of ADI significantly altered the pharmacokinetics of DOX in HCC rats, leading to increased plasma concentrations of both DOX and DOXol. The area under the plasma drug concentration-time curve (AUCs) of DOX and DOXol in rats pretreated with ADI were 3.79-fold and 2.92-fold higher, respectively, than those in control rats that did not receive ADI. Conclusions: Increased levels of DOX and DOXol were found in the plasma of HCC rats pretreated with ADI. [ABSTRACT FROM AUTHOR] |
|
Copyright of BMC Pharmacology & Toxicology is the property of BioMed Central and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| قاعدة البيانات: |
Complementary Index |
Full Text Finder